Biotechnology

Accelerate business growth and deliver environmental benefits by harnessing the novel biotechnologies created by researchers at the University of Edinburgh.

At the University of Edinburgh we use biotechnology to redesign living systems and transform them into biofactories for the more sustainable manufacture of chemicals. Our activities in this space include engineering microbes to produce sustainable alternatives to petrochemicals and novel sources of food, clean up contaminated sites (bioremediation), recover valuable components (resource efficiency), and recycle valuable waste metal (biomining). We also use natural and engineered biocatalysts (enzymes) to generate high-value products, for example drug intermediates, from sustainable building blocks and produce biosensors to monitor environmental pollution.

The University harnesses world-class research capabilities in biological sciences, chemistry, engineering, geosciences, informatics and physics, and we provide our commercial partners with tailored expertise to deliver the environmental benefits, innovative new products, enhanced performance, resource conservation and reduced costs promised by Industrial Biotechnology.

Key areas of expertise

Centre for Synthetic and Systems Biology (known as SynthSys)

SynthSys spans biology, chemistry, physics, informatics, social sciences, engineering, maths, medicine and veterinary sciences. Our researchers explore fundamental biological questions about living cells and systems and apply these insights – often in collaboration with industry – to create innovations for many markets including personal and home care, food and drink, flavours and fragrances, advanced and functional materials, agriculture, the environment, and medicine and healthcare.


Biocompatible chemistry

Merging the flexibility and scope offered by modern synthetic chemistry with the sustainable and programmable features of synthetic biology, biocompatible chemistry aims to harness the best of both worlds to drive a green chemical industry.


Edinburgh Genome Foundry

A fully automated platform to design and assemble DNA up to chromosome length, the Genome Foundry is at the forefront of animal and human health research. It has the capability to rapidly build and test thousands of genetic constructs for academic and industrial customers to equip cells with new or improved functionalities.


Responsible research and innovation (RRI)

The engineering of mammalian systems opens up novel questions for social scientific research. Our leading group of social scientists specialise in synthetic biology and collaborate with SynthSys to foster the design and implementation of sustainable and socially conscious research and innovation.

18 Aug 2022
News 
MiAlgae secures multi-million-pound funding
Biotechnology
Circular economy
Startups and spinouts
Case Study 
Chasing the blues with ScotBio
Biotechnology
Food and drink
Genotype to phenotype
17 May 2022
News 
Old College Capital joins £1m investment in University startup ŌGI Bio
Case Study 
Douglas Martin MiAlgae
MiAlgae: fish-free omega-3
Biotechnology
Circular economy
People, Places and Planet
Startups and spinouts
12 Jan 2022
News 
GHO Capital invests in cell therapy spinout RoslinCT
Bench to Bedside
Biotechnology
Startups and spinouts
Therapeutics
02 Apr 2021
News 
£8.7m collaboration seeks better route to modern medicines
Biotechnology
Case Study 
Bowl of vanilla icecream with sprinkles
Bacteria serves tasty solution to plastic crisis
Biotechnology
People, Places and Planet
Sustainability
Technology 
Identifying structurally stable peptides
A new method for diagnostics and therapeutics development
Biotechnology
Therapeutics
Vaccines
Technology 
Cobalt oxide nanoparticles
An alternative vaccine adjuvant
Biotechnology
Vaccines
Technology 
Engineered reprogramming factors for iPSC generation
A series of engineered molecules that retain a highly specific ability to reprogram adult or fully differentiated cells into pluripotent stem cells only.
Biotechnology
Clinical sciences
Technology 
Novel programmable gene activation system
This novel system is a powerful and versatile synthetic biology tool for diverse research and industrial applications.
Biotechnology
Genetics and cancer
Technology 
Rational CHO cell engineering
For stable recombinant protein expression and production
Biotechnology
Genetics and cancer
Case Study 
Collaborative research in predictive biomarkers
Biotechnology
Clinical sciences
Case Study 
Macomics
Biotechnology
Genetics and cancer
Startups and spinouts
Case Study 
Resolution Therapeutics
Biotechnology
Startups and spinouts
Therapeutics
Tissue regeneration and repair

Find out more

Dr Lorraine Kerr

Commercial Relations Manager
Edinburgh Innovations